Drug profile · INN
alprostadil
CAVERJECT IMPULSE
alprostadil (CAVERJECT IMPULSE) is a prostanoid ep1 receptor agonist. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — alprostadil
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 11
- Programs
- 7
- Data quality
- 0.84
Quick answer
alprostadil (CAVERJECT IMPULSE) is a prostanoid ep1 receptor agonist. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid EP1 receptor agonist
Primary target: Prostaglandin E2 receptor EP1 subtype
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related patents
-
CN 115003329
Parapoxvirus for conditioning and treating coronavirus infections
granted -
BR 112021015776
Edição de gene para hemofilia a com expressão de fator viii melhorada
granted -
DE 102019218587
Kontrastmittelbasierte Gefäßdarstellung
granted -
US 2020384125
GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION
granted -
EP 3728594
MATERIALIEN UND VERFAHREN ZUR BEHANDLUNG DES USHER-SYNDROMS TYP 2A
granted -
CA 3121191
CAS9 DE CODAGE D'ARNM OPTIMISE DESTINE A ETRE UTILISE DANS DES LNP
granted -
CA 3118090
COMPOSITIONS ET PROCEDES POUR EDITION DU GENOME A MEDIATION PAR NHEJ
granted -
CA 3097885
PROCEDES ET COMPOSITIONS D'EPUISEMENT DE LYMPHOCYTES T CYTOTOXIQUES
granted -
CA 3079172
COMPOSITIONS ET METHODES POUR L'EDITION GENIQUE POUR L'HEMOPHILIE A
granted -
WO 2018227427
DÉRIVÉS DE DIAZÉPANE PONTÉS SUBSTITUÉS ET LEUR UTILISATION
granted -
WO 2018128828
NOUVEAUX MIMÉTIQUES D'HEPCIDINE ET LEURS UTILISATIONS
granted
Frequently asked questions
What is alprostadil?
alprostadil (CAVERJECT IMPULSE) is a prostanoid ep1 receptor agonist. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for alprostadil?
CAVERJECT IMPULSE is a marketed brand name for alprostadil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alprostadil?
alprostadil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.